Home Newsfeeds Maxim Group Downgrades Brooklyn to Hold

Maxim Group Downgrades Brooklyn to Hold

Maxim Group analyst Jason McCarthy downgrades Brooklyn (NASDAQ:BTX) from Buy to Hold.

byBenzinga Newsdesk

October 12, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades Brooklyn (NASDAQ:BTX) from Buy to Hold.

United States Steel Posts Q3 Earnings Beat On Improved Steel Shipments, Despite Weak Prices

By Lekha Gupta

October 27, 8:29 AM

United States Steel Corp (NYSE: X) reported Q3 FY23 revenues of $4.43 billion, beating the

Why American Airlines Shares Are Flying Higher Today

By Anusuya Lahiri

January 12, 9:17 AM

American Airlines Group, Inc (NASDAQ:AAL) said it expects fourth-quarter revenue to be better than expected on robust demand for air travel…

AAL

US Stocks Mixed; Coca-Cola Raises FY23 Outlook

By Lisa Levin

July 26, 10:39 AM

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.05% to 35,456.41 while the NASDAQ fell 0.17% to 14,120.66. The S&P 500, also fell, dropping, 0.15% to 4,560.62.

ABVC

EPKINLY Approved By U.S. FDA As The First And Only Bispecific Antibody To Treat Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma

By Benzinga Newsdesk

May 19, 12:37 PM

AbbVie (NYSE:ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLYTM (epcoritamab-bysp), as the first and only T-cell engaging bispecific antibody for the treatment of adult patients

ABBV

Maxim Group Downgrades Brooklyn to Hold

Related Posts

United States Steel Posts Q3 Earnings Beat On Improved Steel Shipments, Despite Weak Prices

Why American Airlines Shares Are Flying Higher Today

US Stocks Mixed; Coca-Cola Raises FY23 Outlook

EPKINLY Approved By U.S. FDA As The First And Only Bispecific Antibody To Treat Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma